HCW Biologics Inc.
HCWB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828673
In the last 90 days, HCW Biologics Inc. insiders filed 3 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $515.7K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding HCW Biologics Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 9 | 13 | +4 |
| Shares | 160.6K | 369.1K | +208.5K (+129.8%) |
| Value | $512.0K | $855.0K | +$343.0K (+67.0%) |
New holders (8)
Institutions that held HCW Biologics Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 124,705 | $289.0K | 0.00% |
| Vanguard Group Inc | 82,521 | $191.0K | 0.00% |
| Bridgeway Capital Management, LLC | 46,600 | $108.0K | 0.00% |
| State Street Corp | 20,100 | $47.0K | 0.00% |
| Cresset Asset Management, LLC | 12,500 | $29.0K | 0.00% |
| Renaissance Technologies LLC | 11,900 | $28.0K | 0.00% |
| Focused Wealth Management, Inc | 1,000 | $2.00K | 0.00% |
| Bank of America Corp | 12 | $0 | 0.00% |
Sold out (4)
Institutions that held HCW Biologics Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Millennium Management LLC | 45,416 | $145.0K |
| UBS Group AG | 37,384 | $119.0K |
| Goldman Sachs Group Inc | 19,785 | $63.0K |
| Tower Research Capital LLC (TRC) | 5,837 | $18.0K |